Denne siden ble automatisk oversatt og nøyaktigheten av oversettelsen er ikke garantert. Vennligst referer til engelsk versjon for en kildetekst.

Translation of Stroke Specific Quality of Life Questionnaire Into Local Languages of Pakistan

30. mars 2022 oppdatert av: Riphah International University

Reliability and Validity of Stroke Specific Quality of Life Scale in Local Languages of Pakistan

The aim of the present study is to translate the Stroke Specific Quality of Life Questionnaire into local languages of Pakistan along with validation of the translated versions by evaluating their validity and reliability in the people of Pakistan, speaking respective languages and suffering from a stroke. No such study has been previously conducted in the Pakistan region which translates the specific questionnaire and follows the proper cross-culture adaptation protocol.

Studieoversikt

Status

Rekruttering

Forhold

Detaljert beskrivelse

The stroke-Specific Quality of Life Scale is regarded as one of the most extensive and more commonly utilized patient-centred and self-reported measure of outcomes in the stroke population. The SS-QoL scale is a health-related outcome measure that comprises 49 items in 12 areas of vision, mobility, thinking, social roles, self-care, language, personality, family roles, work/productivity, upper limb function, mood and energy. It covers a more extensive inclusion of capacities ordinarily influenced by stroke.

The Stroke Specific Quality of Life questionnaire, originally developed in English, has been translated into many languages to assess for its validity and reliability ever since, but not any of the Pakistani native versions are made or tested. Previous studies have shown that the translation of the scale would end up giving a standard measure to be utilized in clinical practices and research studies while sanctioning clinicians and specialists to share information and have an insight into patient's health-related concerns post-stroke. Thus, it is imperative to translate this questionnaire into psychometrically sound versions of indigenous Pakistani languages such as Urdu, Punjabi, Sindhi, Balochi and Pashto. This may promote an easy understanding of the local population in Pakistan where the languages are spoken and will provide a valid measure of stroke-specific health outcomes to be clinically utilized by practitioners and researchers across the country.

Studietype

Observasjonsmessig

Registrering (Forventet)

1125

Kontakter og plasseringer

Denne delen inneholder kontaktinformasjon for de som utfører studien, og informasjon om hvor denne studien blir utført.

Studiekontakt

Studiesteder

  • Pakistan
    • KPK
      • Abbottabad, KPK, Pakistan, 22010
        • Rekruttering
        • Physiotherapy Department WIRS
        • Ta kontakt med:
        • Hovedetterforsker:
          • Ayesha Javed, MSPT(NMPT*)

Deltakelseskriterier

Forskere ser etter personer som passer til en bestemt beskrivelse, kalt kvalifikasjonskriterier. Noen eksempler på disse kriteriene er en persons generelle helsetilstand eller tidligere behandlinger.

Kvalifikasjonskriterier

Alder som er kvalifisert for studier

40 år til 70 år (Voksen, Eldre voksen)

Tar imot friske frivillige

Nei

Kjønn som er kvalifisert for studier

Alle

Prøvetakingsmetode

Ikke-sannsynlighetsprøve

Studiepopulasjon

To meet inclusion criteria, participants diagnosed with stroke (sub-acute/chronic stage), clinically stable, between age 40-70 years and able to read and complete the local language version of SSQoL. Then patient response will be checked on the translated versions.

Beskrivelse

Inclusion Criteria:

  • Patients post-stroke (sub-acute/chronic stage)
  • Participants belonging to Urdu, Punjabi, Sindhi, Balochi and Pashto speaking class
  • Patients should be capable to complete the questionnaire without any help.

Exclusion Criteria:

  • Healthy population
  • Patients at the acute stage of stroke/ TIA.
  • Individuals diagnosed with conditions other than stroke.
  • Individuals with language/ memory problems.
  • Individuals with disability due to any structural/congenital cause.

Studieplan

Denne delen gir detaljer om studieplanen, inkludert hvordan studien er utformet og hva studien måler.

Hvordan er studiet utformet?

Designdetaljer

Hva måler studien?

Primære resultatmål

Resultatmål
Tiltaksbeskrivelse
Tidsramme
Cross-Cultural Translation of Stroke Specific Quality of Life Scale into local languages of Pakistan
Tidsramme: 6 months
The Stroke Specific Quality of Life Scale (SSQoL) is regarded as one of the most extensive and more commonly utilized patient-centred and self-reported measure of outcomes in the stroke population. It is a health-related stroke outcome measure intended to gather all the relevant concerns significant to the stroke population. The responses are obtained via a progression of a series of centred meetings and interviews with concerned post-stroke patients to survey personal satisfaction. The SS-QoL comprises 49 items in 12 areas of vision, mobility, thinking, social roles, self-care, language, personality, family roles, work/productivity, upper limb function, mood and energy. The patient responses are appraised on a Likert scale consisting of 5 points with greater scores demonstrating better capacity. It covers a more extensive inclusion of capacities ordinarily influenced by stroke. Its translation is to be done in the local languages of Pakistan through a rigorous and approved process.
6 months

Sekundære resultatmål

Resultatmål
Tiltaksbeskrivelse
Tidsramme
Reliability and Validity of translated versions
Tidsramme: 6 months
To determine reliability and validity of cross-culturally adapted and the translated versions of SSQoL in stroke patients with respective languages. Reliability or reproducibility refers to the ability of a measure to produce the same results when administered at two or more interval between different visits of the patient and validity is how accurate the tool measures an item it is supposed to. Thus these both are to measured through various parameters to validate the translated versions as appropriate and applicable.
6 months

Samarbeidspartnere og etterforskere

Det er her du vil finne personer og organisasjoner som er involvert i denne studien.

Sponsor

Riphah International University

Publikasjoner og nyttige lenker

Den som er ansvarlig for å legge inn informasjon om studien leverer frivillig disse publikasjonene. Disse kan handle om alt relatert til studiet.

Generelle publikasjoner

Studierekorddatoer

Disse datoene sporer fremdriften for innsending av studieposter og sammendragsresultater til ClinicalTrials.gov. Studieposter og rapporterte resultater gjennomgås av National Library of Medicine (NLM) for å sikre at de oppfyller spesifikke kvalitetskontrollstandarder før de legges ut på det offentlige nettstedet.

Studer hoveddatoer

Studiestart (Faktiske)

10. mars 2021

Primær fullføring (Forventet)

22. april 2022

Studiet fullført (Forventet)

30. april 2022

Datoer for studieregistrering

Først innsendt

8. april 2021

Først innsendt som oppfylte QC-kriteriene

12. april 2021

Først lagt ut (Faktiske)

13. april 2021

Oppdateringer av studieposter

Sist oppdatering lagt ut (Faktiske)

31. mars 2022

Siste oppdatering sendt inn som oppfylte QC-kriteriene

30. mars 2022

Sist bekreftet

1. mars 2022

Mer informasjon

Begreper knyttet til denne studien

Nøkkelord

Ytterligere relevante MeSH-vilkår

Andre studie-ID-numre

  • REC/00960 Ayesha Javed

Plan for individuelle deltakerdata (IPD)

Planlegger du å dele individuelle deltakerdata (IPD)?

NEI

Legemiddel- og utstyrsinformasjon, studiedokumenter

Studerer et amerikansk FDA-regulert medikamentprodukt

Nei

Studerer et amerikansk FDA-regulert enhetsprodukt

Nei

Denne informasjonen ble hentet direkte fra nettstedet clinicaltrials.gov uten noen endringer. Hvis du har noen forespørsler om å endre, fjerne eller oppdatere studiedetaljene dine, vennligst kontakt register@clinicaltrials.gov. Så snart en endring er implementert på clinicaltrials.gov, vil denne også bli oppdatert automatisk på nettstedet vårt. .

Abonnere